ImmunityBio (IBRX) Invested Capital (2013 - 2026)
ImmunityBio (IBRX) reported Invested Capital of -$389.1 million for Q1 2026, down 355.21% year-over-year from $152.5 million in Q1 2025, and down 1.68% quarter-over-quarter from -$382.7 million in Q4 2025.
ImmunityBio (IBRX) Invested Capital (2013 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 14 years of Invested Capital data on file, last reported at -$389.1 million in Q1 2026.
- Invested Capital for Q1 2026 came in at -$389.1 million, down 355.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$389.1 million (down 355.21% YoY), and the FY2025 annual result was -$382.7 million, down 288.17% from the prior year.
- Invested Capital slipped to -$389.1 million in Q1 2026 per IBRX's latest filing, from -$382.7 million in the prior quarter.
- Over five years, Invested Capital peaked at $203.4 million in Q4 2024 and troughed at -$645.2 million in Q2 2023.
- A 5-year average of -$364.3 million and a median of -$389.1 million in 2026 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2026: Invested Capital soared 152.7% in 2024, then slumped 355.21% in 2026.
- A 5-year view of Invested Capital shows it stood at -$395.7 million in 2022, then advanced by 2.46% to -$385.9 million in 2023, then soared by 152.7% to $203.4 million in 2024, then sank by 288.17% to -$382.7 million in 2025, then dropped by 1.68% to -$389.1 million in 2026.
- Business Quant data shows IBRX's Invested Capital at -$389.1 million in Q1 2026, -$382.7 million in Q4 2025, and -$387.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -389.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -389.13 Mn |
| Dec 31, 2025 | -382.70 Mn |
| Sep 30, 2025 | -387.10 Mn |
| Jun 30, 2025 | -64.82 Mn |
| Mar 31, 2025 | -85.48 Mn |
| Dec 31, 2024 | 203.38 Mn |
| Sep 30, 2024 | -386.19 Mn |
| Jun 30, 2024 | -588.57 Mn |
| Mar 31, 2024 | -584.35 Mn |
| Dec 31, 2023 | -385.94 Mn |
| Sep 30, 2023 | -410.65 Mn |
| Jun 30, 2023 | -645.18 Mn |
| Mar 31, 2023 | -501.72 Mn |
| Dec 31, 2022 | -395.69 Mn |
| Sep 30, 2022 | -429.08 Mn |
| Jun 30, 2022 | -421.97 Mn |
| Mar 31, 2022 | -337.56 Mn |
| Dec 31, 2021 | -243.91 Mn |
| Sep 30, 2021 | -181.25 Mn |
| Jun 30, 2021 | -141.87 Mn |